MA35367B1 - Cigarette electronique - Google Patents

Cigarette electronique

Info

Publication number
MA35367B1
MA35367B1 MA35534A MA35534A MA35367B1 MA 35367 B1 MA35367 B1 MA 35367B1 MA 35534 A MA35534 A MA 35534A MA 35534 A MA35534 A MA 35534A MA 35367 B1 MA35367 B1 MA 35367B1
Authority
MA
Morocco
Prior art keywords
electronic cigarette
nicotine
relates
present
atomized
Prior art date
Application number
MA35534A
Other languages
English (en)
Inventor
Said Bakraoui
Original Assignee
Said Bakraoui
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Said Bakraoui filed Critical Said Bakraoui
Priority to MA35534A priority Critical patent/MA35367B1/fr
Publication of MA35367B1 publication Critical patent/MA35367B1/fr

Links

Landscapes

  • Manufacture Of Tobacco Products (AREA)

Abstract

La présente invention concerne une cigarette électronique, en particulier ne contient pas de goudron, de nicotine (nicotine) ne contenant que la cigarette électronique atomisé.
MA35534A 2013-01-04 2013-01-04 Cigarette electronique MA35367B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MA35534A MA35367B1 (fr) 2013-01-04 2013-01-04 Cigarette electronique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MA35534A MA35367B1 (fr) 2013-01-04 2013-01-04 Cigarette electronique

Publications (1)

Publication Number Publication Date
MA35367B1 true MA35367B1 (fr) 2014-09-01

Family

ID=51870759

Family Applications (1)

Application Number Title Priority Date Filing Date
MA35534A MA35367B1 (fr) 2013-01-04 2013-01-04 Cigarette electronique

Country Status (1)

Country Link
MA (1) MA35367B1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019222456A1 (fr) * 2018-05-16 2019-11-21 Intrepid Brands, LLC Milieu chauffant à radiofréquence

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019222456A1 (fr) * 2018-05-16 2019-11-21 Intrepid Brands, LLC Milieu chauffant à radiofréquence

Similar Documents

Publication Publication Date Title
UY34824A (es) Nucleósidos de espirooxetano de uracilo
PH12014502350A1 (en) Mixtures, methods and compositions pertaining to conductive materials
EA201991715A1 (ru) Композиции, содержащие антитело к pdl1
MX2021015825A (es) Formulaciones de anticuerpos estables acuosas.
TWD163815S (zh) 車輛之尾燈
EA201591750A1 (ru) Антитела против b7-h4 и иммуноконъюгаты
UY34778A (es) ?COMPUESTOS DE HEXAHIDROPIRANO[3,4-d][1,3]TIAZIN-2-AMINA HETEROCÍCLICOS SUSTITUÍDOS?.
UY34817A (es) Tienopirimidinas
TWD162041S (zh) 飾品
BR112016015105A2 (pt) Conjugados var2csa-droga
EA201600390A1 (ru) КОМПОЗИЦИЯ 1,5-ДИМЕТИЛ-6-ТИОКСО-3-(2,2,7-ТРИФТОР-3-ОКСО-4-(ПРОП-2-ИНИЛ)-3,4-ДИГИДРО-2H-БЕНЗО[b][1,4]ОКСАЗИН-6-ИЛ)-1,3,5-ТРИАЗИНАН-2,4-ДИОНА
WO2014043362A3 (fr) Génération d'un profil de point d'intérêt sur la base de commentaires sociaux de tiers
MA38500A1 (fr) Systèmes et procédés pour analyser une nourriture pour animal
EA201591712A1 (ru) Антибиотические композиции на основе цефтолозана
BR112018011526A2 (pt) compostos policíclicos como inibidores da tirosina quinase de bruton
UY34586A (es) Nuevas 5,8-dihidro-6h-pirazolo[3,4-h]quinazolinas como inhibidores de igf-1r/ir
CU24398B1 (es) 3-(piperidin,pirrol o azetidin)-indoles sustituidos útiles como inhibidores rorc2
MX2015013363A (es) Heteroarildihidropirimidina (hap) fluorescente: tinte de diagnostico para nucleos de virus de la hep b (hbv) en celulas.
MX2015015906A (es) Mejoras en o con relacion a compuestos organicos.
EA201690244A1 (ru) Ингибиторы киназ на основе простых ариловых эфиров
TWD160421S (zh) 手錶
GB2523917A (en) Integration of signal sampling within transistor amplifier stage
EA201600003A1 (ru) КОМБИНАЦИИ ДЛЯ ЛЕЧЕНИЯ РАКА, СОДЕРЖАЩИЕ ИНГИБИТОР Mps-1 КИНАЗЫ И ИНГИБИТОР МИТОЗА
MA39190B1 (fr) Dérivés d'imidazolyle fusionnés, leur préparation et leur utilisation en tant que médicaments
MA39126A2 (fr) Synthèse d'enantiomère de progestérone et d'intermédiaires de celui-ci